Articles producció científica> Bioquímica i Biotecnologia

How Did the COVID-19 Lockdown Pandemic Affect the Depression Symptomatology in Mediterranean Older Adults with Metabolic Syndrome?

  • Datos identificativos

    Identificador: imarina:9326311
    Handle: https://hdl.handle.net/20.500.11797/imarina9326311
    Autores:
    Paz-Graniel, IBabio, NNishi, SKMartinez-Gonzalez, MACorella, DFito, MMartinez, AAlonso-Gomez, AMWarnberg, JVioque, JRomaguera, DLopez-Miranda, JEstruch, RTinahones, FJSantos-Lozano, JMSerra-Majem, JLBueno-Cavanillas, ATur, JASanchez, VMPinto, XDelgado-Rodriguez, MMatia-Martin, PVidal, JCalderon-Sanchez, CDaimiel, LRos, EFernandez-Aranda, FToledo, EValle-Hita, CSorli, JVLassale, CGarcia-Rios, AOncina-Canovas, ABaron-Lopez, FJZulet, MARayo, ECasas, RThomas-Carazo, ETojal-Sierra, LDamas-Fuentes, MRuiz-Canela, Mde las Heras-delgado, SFernandez-Carrion, RCastaner, OPena-Orihuela, PJGonzalez-Palacios, SBuil-Cosiales, PGoday, ASalas-Salvado, J
    Resumen:
    Background and Aims. To control the COVID-19 spread, in March 2020, a forced home lockdown was established in Spain. In the present study, we aimed to assess the effect of mobility and social COVID-19-established restrictions on depressive symptomatology in older adults with metabolic syndrome. We hypothesize that severe restrictions might have resulted in detrimental changes in depressive symptomatology. Methods. 2,312 PREDIMED-Plus study participants ( men = 53.9 %; mean age = 64.9 ± 4.8 years) who completed a COVID-19 lockdown questionnaire to assess the severity of restrictions/lockdown and the validated Spanish version of the Beck Depression Inventory-II (BDI-II) during the three established phases concerning the COVID-19 lockdown in Spain (prelockdown, lockdown, and postlockdown) were included in this longitudinal analysis. Participants were categorized according to high or low lockdown severity. Analyses of covariance were performed to assess changes in depressive symptomatology across lockdown phases. Results. No significant differences in participant depression symptomatology changes were observed between lockdown severity categories (low/high) at the studied phases. During the lockdown phase, participants showed a decrease in BDI-II score compared to the prelockdown phase (mean (95% CI), -0.48 (-0.24, -0.72), P < 0.001 ); a nonsignificantly larger decrease was observed in participants allocated in the low-lockdown category (low: -0.59 (-0.95, -0.23), high: -0.43 (-0.67, -0.19)). Similar decreases in depression symptomatology were found for the physical environment dimension. The post- and prelockdown phase BDI-II scores were roughly similar. Conclusions. The COVID-19 pandemic lockdown was associated with a decrease in depressive symptomatology that returned to

  • Otros:

    Autor según el artículo: Paz-Graniel, I; Babio, N; Nishi, SK; Martinez-Gonzalez, MA; Corella, D; Fito, M; Martinez, A; Alonso-Gomez, AM; Warnberg, J; Vioque, J; Romaguera, D; Lopez-Miranda, J; Estruch, R; Tinahones, FJ; Santos-Lozano, JM; Serra-Majem, JL; Bueno-Cavanillas, A; Tur, JA; Sanchez, VM; Pinto, X; Delgado-Rodriguez, M; Matia-Martin, P; Vidal, J; Calderon-Sanchez, C; Daimiel, L; Ros, E; Fernandez-Aranda, F; Toledo, E; Valle-Hita, C; Sorli, JV; Lassale, C; Garcia-Rios, A; Oncina-Canovas, A; Baron-Lopez, FJ; Zulet, MA; Rayo, E; Casas, R; Thomas-Carazo, E; Tojal-Sierra, L; Damas-Fuentes, M; Ruiz-Canela, M; de las Heras-delgado, S; Fernandez-Carrion, R; Castaner, O; Pena-Orihuela, PJ; Gonzalez-Palacios, S; Buil-Cosiales, P; Goday, A; Salas-Salvado, J
    Departamento: Bioquímica i Biotecnologia
    Autor/es de la URV: Babio Sánchez, Nancy Elvira / De las Heras Delgado, Sara / Nishi, Stephanie Kimiko / Paz Graniel, Indira del Socorro / Salas Salvadó, Jorge / Valle Hita, Cristina
    Resumen: Background and Aims. To control the COVID-19 spread, in March 2020, a forced home lockdown was established in Spain. In the present study, we aimed to assess the effect of mobility and social COVID-19-established restrictions on depressive symptomatology in older adults with metabolic syndrome. We hypothesize that severe restrictions might have resulted in detrimental changes in depressive symptomatology. Methods. 2,312 PREDIMED-Plus study participants ( men = 53.9 %; mean age = 64.9 ± 4.8 years) who completed a COVID-19 lockdown questionnaire to assess the severity of restrictions/lockdown and the validated Spanish version of the Beck Depression Inventory-II (BDI-II) during the three established phases concerning the COVID-19 lockdown in Spain (prelockdown, lockdown, and postlockdown) were included in this longitudinal analysis. Participants were categorized according to high or low lockdown severity. Analyses of covariance were performed to assess changes in depressive symptomatology across lockdown phases. Results. No significant differences in participant depression symptomatology changes were observed between lockdown severity categories (low/high) at the studied phases. During the lockdown phase, participants showed a decrease in BDI-II score compared to the prelockdown phase (mean (95% CI), -0.48 (-0.24, -0.72), P < 0.001 ); a nonsignificantly larger decrease was observed in participants allocated in the low-lockdown category (low: -0.59 (-0.95, -0.23), high: -0.43 (-0.67, -0.19)). Similar decreases in depression symptomatology were found for the physical environment dimension. The post- and prelockdown phase BDI-II scores were roughly similar. Conclusions. The COVID-19 pandemic lockdown was associated with a decrease in depressive symptomatology that returned to prelockdown levels after the lockdown. The degree of lockdown was not associated with depressive symptomatology. The potential preventive role of the physical environment and social interactions on mental disorders during forced home lockdown should be further studied. This trial is registered with ISRCTN89898870. Retrospectively registered on 24 July 2014.
    Áreas temáticas: Saúde coletiva Psychology, clinical Psychology Psychiatry and mental health Psychiatry Psicología Medicina ii Medicina i Interdisciplinar General medicine Engenharias iv Educação física Clinical psychology Ciencias sociales Ciências biológicas ii
    Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
    Direcció de correo del autor: sara.delasheras@urv.cat stephanie.nishi@urv.cat indiradelsocorro.paz@urv.cat sara.delasheras@urv.cat cristina.valle@urv.cat indiradelsocorro.paz@urv.cat jordi.salas@urv.cat nancy.babio@urv.cat
    Identificador del autor: 0000-0002-3204-6877 0000-0002-3204-6877 0000-0003-2700-7459 0000-0003-3527-5277
    Fecha de alta del registro: 2024-08-03
    Versión del articulo depositado: info:eu-repo/semantics/publishedVersion
    Enlace a la fuente original: https://www.hindawi.com/journals/da/2023/6765950/
    URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referencia al articulo segun fuente origial: Depression And Anxiety. 2023
    Referencia de l'ítem segons les normes APA: Paz-Graniel, I; Babio, N; Nishi, SK; Martinez-Gonzalez, MA; Corella, D; Fito, M; Martinez, A; Alonso-Gomez, AM; Warnberg, J; Vioque, J; Romaguera, D; (2023). How Did the COVID-19 Lockdown Pandemic Affect the Depression Symptomatology in Mediterranean Older Adults with Metabolic Syndrome?. Depression And Anxiety, 2023(), -. DOI: 10.1155/2023/6765950
    DOI del artículo: 10.1155/2023/6765950
    Entidad: Universitat Rovira i Virgili
    Año de publicación de la revista: 2023
    Tipo de publicación: Journal Publications

  • Palabras clave:

    Clinical Psychology,Psychiatry,Psychiatry and Mental Health,Psychology,Psychology, Clinical
    Saúde coletiva
    Psychology, clinical
    Psychology
    Psychiatry and mental health
    Psychiatry
    Psicología
    Medicina ii
    Medicina i
    Interdisciplinar
    General medicine
    Engenharias iv
    Educação física
    Clinical psychology
    Ciencias sociales
    Ciências biológicas ii

  • Documentos:

    DocumentPrincipal

  • Cerca a google

    Search to google scholar